Literature DB >> 30616363

One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.

Yasutaka Yamauchi1, Mitsuyoshi Takahara2, Yoshiaki Shintani3, Osamu Iida4, Teruyasu Sugano5, Yoshito Yamamoto6, Daizo Kawasaki7, Masahiko Fujihara8, Keisuke Hirano9, Hiroyoshi Yokoi10, Akira Miyamoto1, Masato Nakamura11.   

Abstract

Keywords:  angiography; angioplasty; peripheral arterial disease; quality of life; stents

Year:  2019        PMID： 30616363     DOI： 10.1161/CIRCINTERVENTIONS.118.007441

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  4 in total

1.  Efficacy of three-dimensional roadmapping by fusion of computed tomography angiography with volumetric data from an angiography machine in endovascular therapy for iliac chronic total occlusion: a case report.

Authors:  Naoki Hayakawa; Satoshi Kodera; Noriyoshi Ohki; Junji Kanda
Journal:  CVIR Endovasc       Date:  2019-10-21

2.  Impact of Hospital Volume on Clinical Outcomes after Aortoiliac Stenting in Patients with Peripheral Artery Disease.

Authors:  Osamu Iida; Mitsuyoshi Takahara; Yasutaka Yamauchi; Yoshiaki Shintani; Teruyasu Sugano; Yoshito Yamamoto; Daizo Kawasaki; Hiroyoshi Yokoi; Akira Miyamoto; Toshiaki Mano; Masato Nakamura
Journal:  J Atheroscler Thromb       Date:  2019-10-05       Impact factor: 4.928

3.  Evidence-Experience Gap and Future Perspective on the Treatment of Peripheral Artery Disease.

Authors:  Osamu Iida; Mitsuyoshi Takahara; Toshiaki Mano
Journal:  J Atheroscler Thromb       Date:  2021-06-02       Impact factor: 4.928

4.  Thrombotic Lesions are Associated with Poor Outcomes after Endovascular Treatment in Patients with Non-Acute Aortoiliac Total Occlusions.

Authors:  Yoshito Kadoya; Kan Zen; Osamu Iida; Yoshito Yamamoto; Daizo Kawasaki; Yasutaka Yamauchi; Yoshiaki Shintani; Teruyasu Sugano; Hiroyoshi Yokoi; Satoaki Matoba; Masato Nakamura
Journal:  J Atheroscler Thromb       Date:  2021-02-10       Impact factor: 4.928
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.